Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Net Cash Flow (2016 - 2017)

Tenax Therapeutics' Net Cash Flow history spans 8 years, with the latest figure at -$159073.0 for Q4 2017.

  • For Q4 2017, Net Cash Flow fell 101.7% year-over-year to -$159073.0; the TTM value through Dec 2017 reached -$8.4 million, down 230.39%, while the annual FY2025 figure was $2.7 million, 96.81% down from the prior year.
  • Net Cash Flow for Q4 2017 was -$159073.0 at Tenax Therapeutics, up from -$469803.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at $9.4 million in Q4 2016 and bottomed at -$36.4 million in Q3 2014.
  • The 5-year median for Net Cash Flow is -$1.3 million (2016), against an average of -$2.7 million.
  • The largest annual shift saw Net Cash Flow plummeted 1205.42% in 2014 before it surged 9458.99% in 2016.
  • A 5-year view of Net Cash Flow shows it stood at $6.2 million in 2013, then crashed by 221.75% to -$7.6 million in 2014, then soared by 98.68% to -$100160.0 in 2015, then soared by 9458.99% to $9.4 million in 2016, then crashed by 101.7% to -$159073.0 in 2017.
  • Per Business Quant, the three most recent readings for TENX's Net Cash Flow are -$159073.0 (Q4 2017), -$469803.0 (Q3 2017), and -$4.8 million (Q2 2017).